Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

External Beam Radiotherapy for Bone Metastases

CBE ID
1822
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

This measure reports the percentage of patients, regardless of age, with a diagnosis of painful bone metastases and no history of previous radiation who receive external beam radiation therapy (EBRT) with an acceptable fractionation scheme as defined by the guideline.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      No
      1.14 Numerator

      All patients, regardless of age, with painful bone metastases, and no previous radiation to the same anatomic site who receive EBRT with any of the following recommended fractionation schemes: 30Gy/10fxns, 24Gy/6fxns, 20Gy/5fxns, 8Gy/1fxn.

      1.15 Denominator

      All patients with painful bone metastases and no previous radiation to the same anatomic site who receive EBRT

      Exclusions

      The medical reasons for denominator exclusions are:
      1) Previous radiation treatment to the same anatomic site;
      2) Patients with femoral axis cortical involvement greater than 3 cm in length;
      3) Patients who have undergone a surgical stabilization procedure; and
      4) Patients with spinal cord compression, cauda equina compression or radicular pain

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cancer Fall Cycle 2017
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      American Society for Radiation Oncology
      Steward POC email
                Public Comments